Company News for May 4, 2026

Zacks Zacks Ouvrir sur Zacks
Company News for May 4, 2026
Shares of Newell Brands Inc. ( NWL) surged 11.5% after the company reported a first-quarter 2026 loss of $0.05 per share, narrower than the Zacks Consensus Estimate of a loss of $0.09 per share.  Colgate-Palmolive Company’s ( CL) shares gained 2.2% after the company reported first-quarter 2026 earnings of $0.97 per share, beating the Zacks Consensus Estimate of $0.95 per share. Shares of The Estée Lauder Companies Inc. ( EL) jumped 3.4% after the company reported third-quarter fiscal 2026 earnings of $0.91 per share, surpassing the Zacks Consensus Estimate of $0.66 per share. Shares of iRadimed Corporation ( IRMD) rose 4.5% after the company reported first-quarter 2026 earnings of $0.49 per share, outpacing the Zacks Consensus Estimate of $0.45 per share. 

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Newell Brands Inc. (NWL): Free Stock Analysis Report
 
Colgate-Palmolive Company (CL): Free Stock Analysis Report
 
The Estee Lauder Companies Inc. (EL): Free Stock Analysis Report
 
iRadimed Corporation (IRMD): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research